|
|
||||||||

*
Department of Immunology, Faculty of Medicine, Hospital Reina Sofía, University of Córdoba, Córdoba, Spain; and
Centro de Biología Molecular, University Autónoma of Madrid, Madrid, Spain
It has been described that peptides derived from a highly conserved
region of the
1 helix of the first domain of HLA class I Ags exhibit
immunomodulatory capacity blocking both T and NK cell cytotoxicity. In
vivo treatment with these peptides prolongs survival of MHC-mismatched
allografts. However, the molecular bases of these effects are still
unclear. In this study, we further analyze the mechanisms by which the
dimeric peptide HLA-B2702 (7783/8377) induces suppression of NK
cell cytotoxicity. This peptide inhibits natural and redirected lysis
mediated by NK cells without significantly affecting effector-target
cell binding. We have also isolated and sequenced a protein that
binds this inhibitory peptide, which structurally corresponds to
ß-tubulin. Tubulin is the major protein of microtubules and is
involved in target cell killing. Furthermore, B2702 peptide promotes
GTP-independent tubulin assembly, producing aggregates that cannot be
depolymerized by cold. Treatment of NK cells with Taxol or demecolcine,
which interfere with microtubule organization, also prevents NK cell
cytotoxicity. Taken together, these results support the hypothesis that
the peptide B2702 (7783/8377) exerts its inhibitory effect on NK
cell cytotoxicity by inducing polymerization of microtubules and
interfering with their normal assembly/disassembly
dynamics.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |